SCHEMBL16145392

SCHEMBL16145392

Cn1nc(-c2ccc(Cl)cc2)nc1C1=C(O)C(C)(C2CC2)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 4/20 0.44
NR1H2 P55055 3/20 0.44
MAPT P10636 4/20 0.42
NPC1 O15118 2/20 0.42
RECQL P46063 2/20 0.42
RAB9A P51151 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
POLB P06746 2/20 0.42
THRB P10828 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
S1PR2 O95136 1/20 0.42
TDP2 O95551 1/20 0.42
S1PR4 O95977 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
RAF1 P04049 1/20 0.42
HPGD P15428 1/20 0.42
S1PR1 P21453 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16153993 0.89 NR1H3 (0.46) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL14691676 0.85 NR1H3 (0.50) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL14690502 0.80 NR1H2 (0.45) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL16153982 0.75 NR1H3 (0.49) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL16153976 0.74 NR1H3 (0.51) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL16153985 0.74 NR1H3 (0.44) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL2363264 0.74 ACACB (0.62) L3MBTL1TDP2MAP2K1ACACBACACA
SCHEMBL16154006 0.73 KDM4C (0.47) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL16153974 0.73 NR1H3 (0.53) NR1H3NR1H2MAPTNPC1RECQL
SCHEMBL14691803 0.73 NR1H3 (0.50) NR1H3NR1H2MAPTNPC1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9198432-B2 1,2,4-triazolyl-substituted ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-01 US disclosed
US-9198432-B2 1,2,4-triazolyl-substituted ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-01 US disclosed
US-9198432-B2 1,2,4-triazolyl-substituted ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-01 US disclosed
US-20140302988-A1 1,2,4-Triazolyl-Substituted Ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-09 US disclosed
US-20140302988-A1 1,2,4-Triazolyl-Substituted Ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-09 US disclosed
US-20140302988-A1 1,2,4-Triazolyl-Substituted Ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140302988-A1 1,2,4-Triazolyl-Substituted Ketoenols PIKFYVE, PHYKPL, KCNE1 NR1H3 1852/4885NR1H2 2368/4885MAPT 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.